Lesson plan
Obefazimod
Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis. It is miR-124 micro RNA upregulator. Obefazimod was developed by the French biotech company Abivax SA, whose shares rose by more than 500% when the phase 3 data showed promising results.
Article summary
Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis. It is miR-124 micro RNA upregulator. Obefazimod was developed by the French biotech company Abivax SA, whose shares rose by more than 500% when the phase 3 data showed promising results.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.